Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Ahmed Ahmed


Dr Kenta Masuda, MD, PhD, Postdoctoral Research Scientist

 Kenta Masuda

I am a Professor of Gynaecological Oncology at the Nuffield Department of Obstetrics and Gynaecology at the University of Oxford and a Consultant Gynaecological Oncology Surgeon at the Oxford Cancer and Haematology Centre and is a Fellow of St Hugh’s College. I lead laboratory-based translational research in Gynaecological Oncology. My main research interest is in the surgical, medical and fundamental research into ovarian cancer. I graduated from Ain Shams University in Cairo, Egypt and completed my PhD and Gynaecological Oncology Surgical training at the University of Cambridge. I received my postdoctoral research training at the University of Cambridge and at the University of Texas, M.D. Anderson Cancer Centre in the USA. I was appointed as a Clinical Reader in Oxford in 2010 and became a Medical Research Council Senior Clinical Research Fellow at the Weatherall Institute of Molecular Medicine and Professor of Gynaecological Oncology in 2012. 

Ahmed Ahmed


Professor of Gynaecological Oncology

  • Consultant Gynaecological Oncology Surgeon
  • Director of the Ovarian Cancer Cell Laboratory at the Weatherall Institute of Molecular Medicine


"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer"

Click here to read more


Our group is interested in investigating the mechanistic basis of ovarian cancer development, progression and resistance to therapy. We are interested in understanding the key initiating factors that determine how precursor cells develop into tumours and how such tumours evolve under therapeutic selection. Our aim is to translate such understanding into early detection methods for women who are at high risk of ovarian cancer and to develop novel therapeutic approaches to prevent recurrence of ovarian cancers following primary treatment. We combine novel surgical techniques in prospective clinical trials with mechanistic laboratory investigations to achieve our goals. 

Watch Ahmed talk about his research

False False

Key publications


Recent Publications

5 View 30 more »